-
Dextran Sulfate Effects EMT of Human Gastric Cancer Cells by Reducing HIF-1α/ TGF-β
Dextran Sulfate Effects EMT of Human Gastric Cancer Cells by Reducing HIF-1α/ TGF-β
See More
-
Dextran sulfate low molecular weight for the treatment of amyotrophic lateral sclerosis
On 21 August 2020, orphan designation EU/3/20/2318 was granted by the European Commission to TikoMed AB, Sweden, for dextran sulfate low molecular weight (also known as ILB) for the treatment of amyotrophic lateral sclerosis....
See More
ChatNow